Where the cash went

AB Dynamics (LSE:ABDP) ended its 2026 financial year with net cash of £24.5m, down from £41.4m a year earlier, according to the final results it published on 10 November. The Balance Sheet shows how the group spent the year and how much room it keeps for the next.

The results show adjusted Operating Cash Flow of £13.6m, roughly half the prior year's level. Cash conversion fell to 61% from 106%. Management attributed the weaker conversion mainly to customer deliveries being concentrated towards the end of the year, leaving more cash tied up in receivables at the year end.

Spending also rose. Acquisitions absorbed more than £15m, mainly the purchase of eMpulse Test Systems, announced in August, and deferred consideration on an earlier deal. Capital Expenditure and product development, together with dividends, share purchases and Lease payments, took the rest of the gap.

About the company

AB Dynamics is a UK-based supplier of testing and simulation technology to the automotive industry. Its customers include vehicle manufacturers, component suppliers, regulators and independent test houses, and its work centres on proving that vehicles and their driver assistance features perform safely. The group reports across three areas: Testing Products, Simulation and Testing Services, selling a mix of equipment, driving simulators and track-based testing work.

Demand for this kind of equipment follows two forces. One is regulation, as safety authorities introduce new test protocols and mandates. The other is the development cycle of carmakers, which spend on testing when they launch new platforms and technologies. Both forces can produce uneven order timing, which is a recurring theme in the group's results.

A Business built on safety regulation

LSE:ABDP designs and supplies testing equipment, track testing services and driving simulators to vehicle manufacturers, suppliers, regulators and test houses. Its products are used to verify advanced driver assistance systems, which regulators and safety rating bodies increasingly require.

Group Revenue fell 12% to £91.6m and adjusted operating profit fell 18% to £18.3m. Testing Products revenue dropped 21% to £58.4m, partly because the prior year included a non-recurring robot delivery to a North American manufacturer, while Simulation grew 10% to £24.7m. Asia Pacific supplied 40% of revenue, North America 31% and Europe 29%.

Why the balance sheet matters now

The group still has headroom. The presentation cited cash on hand of £27.1m, a £17.5m revolving Credit Facility extended to February 2029 and Debt capacity of about £45m at two times EBITDA. That combination means the reduced net cash figure does not, on its own, constrain the four capital allocation priorities management set out: organic investment, earnings-accretive acquisitions, a progressive Dividend and share buybacks.

LSE:ABDP has proposed a final dividend of 7.00p, up 10%, taking the total for the year to 10.08p. It also intends to seek Shareholder authority at its January 2027 Annual General Meeting to buy back shares, partly to cover obligations under long-term incentive plans. On 10 November, the interim chief financial officer disclosed a purchase of 2,000 shares at 782.14p.

Risks and dependencies

The cash picture depends on whether the late-year receivables convert as expected. If delivery timing again bunches at the year end, reported conversion could remain volatile. Management described the automotive industry as facing unprecedented dislocation, citing weak European conditions, geopolitical events and currency movements.

The year-end order book of £31m was slightly lower than the £32m a year earlier, giving modest visibility. Most of the overhead savings achieved in FY26 are expected to reverse as the group reinvests in innovation, sales and routes to market, so cost cuts will not support profit in the same way next year. Integration of eMpulse adds execution risk, and simulator sales are individually large, making timing lumpy.

Interpreting the fall in cash conversion

Cash conversion of 61%, against 106% a year earlier, is the most striking number in the update, but the explanation offered is about timing rather than profitability. Customer deliveries were concentrated towards the end of the year, so invoices raised late in the period had not been paid by the balance sheet date. Adjusted operating cash flow of £13.6m, roughly half the prior year, reflects that build in receivables.

The distinction matters because the two readings point in opposite directions. If the late deliveries convert to cash in the first half of FY27, conversion should recover and net cash can rebuild. If delivery timing continues to bunch at year end, reported conversion could stay volatile even when underlying trading is steady. The group's simulator sales, which are individually large, add to that lumpiness.

Revenue mix and regional spread

The revenue decline of 12% to £91.6m was driven by Testing Products, down 21% to £58.4m, partly because the previous year included a non-recurring robot delivery to a North American manufacturer. Simulation grew 10% to £24.7m, which shows that Demand in that area was not uniformly weak. The regional split, with Asia Pacific at 40%, North America at 31% and Europe at 29%, spreads the group's exposure across the three largest automotive regions, but it also means that weakness in any one of them is visible in the totals.

Adjusted operating profit fell by a larger proportion than revenue, down 18% to £18.3m, which indicates some Operating Leverage working in reverse: when sales fall, fixed costs absorb a bigger share of the income. The company said most of the overhead savings made in FY26 would reverse as it reinvests, so cost control is not expected to provide the same support next year.

Capital allocation priorities in context

The four stated priorities, organic investment, earnings-accretive acquisitions, a progressive dividend and share buybacks, compete for the same pool of cash. With net cash of £24.5m, cash on hand of £27.1m and debt capacity of about £45m at two times EBITDA, the group can pursue more than one at a time, but not all at full scale. The eMpulse purchase, deferred consideration and the planned VadoTech closure show that management is reshaping the portfolio while keeping the dividend moving upwards, with the final payment of 7.00p, up 10%, lifting the total to 10.08p.

What the company expects next

Management expects FY27 adjusted operating profit to be in line with analyst consensus, which the company put at about £19.7m based on eight forecasts. Regulatory drivers such as mandatory automatic emergency braking in the United States by 2029 and expanding test protocols in Europe, China and India were cited as support.

The closure of the VadoTech testing services business is scheduled for the first half of FY27, and a new Simulation facility forms part of the operational plan. The next fixed date disclosed is the January 2027 annual general meeting, where the buyback authority will be voted on. Investors will judge capital discipline by first-half cash conversion, the pace of any further acquisitions and whether net cash rebuilds.